Myeloproliferative neoplasms trials in Russia

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Asciminib Roll-over Study

  Where

  Moscow, Saint Petersburg

  Age

  7 years to 100 years

  People

  347 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04877522 · EU 2023-507557-16-00
• Phase 2Taking people
  Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

  Where

  Saint Petersburg

  Age

  18 years to 75 years

  People

  88

  Run by

  St. Petersburg State Pavlov Medical University

  See details and how to joinNCT06532084
• Phase 2Taking people
  BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

  Where

  Saint Petersburg

  Age

  18 years to 75 years

  People

  220

  Run by

  St. Petersburg State Pavlov Medical University

  See details and how to joinNCT06477549